These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21751604)

  • 1. Incidence of ESBL producers amongst Gram-negative bacilli isolated from intra-abdominal infections across India (based on SMART study, 2007 data).
    Chaudhuri BN; Rodrigues C; Balaji V; Iyer R; Sekar U; Wattal C; Chitnis DS; Dhole TN; Joshi S
    J Assoc Physicians India; 2011 May; 59():287-92. PubMed ID: 21751604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
    Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
    Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
    Hsueh PR; Snyder TA; Dinubile MJ; Satischandran V; McCarroll K; Chow JW;
    Int J Antimicrob Agents; 2006 Sep; 28(3):238-43. PubMed ID: 16904295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
    Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Paterson DL; Rossi F; Baquero F; Hsueh PR; Woods GL; Satishchandran V; Snyder TA; Harvey CM; Teppler H; Dinubile MJ; Chow JW
    J Antimicrob Chemother; 2005 Jun; 55(6):965-73. PubMed ID: 15849262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Chow JW; Satishchandran V; Snyder TA; Harvey CM; Friedland IR; Dinubile MJ
    Surg Infect (Larchmt); 2005; 6(4):439-48. PubMed ID: 16433608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
    Zaki Mel S
    J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006.
    Chen WY; Jang TN; Huang CH; Hsueh PR
    J Microbiol Immunol Infect; 2009 Aug; 42(4):317-23. PubMed ID: 19949755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
    Rossi F; Baquero F; Hsueh PR; Paterson DL; Bochicchio GV; Snyder TA; Satishchandran V; McCarroll K; DiNubile MJ; Chow JW
    J Antimicrob Chemother; 2006 Jul; 58(1):205-10. PubMed ID: 16717055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
    Villar HE; Baserni MN; Jugo MB
    J Infect Dev Ctries; 2013 Aug; 7(8):630-4. PubMed ID: 23949299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of extended spectrum beta lactamase mediated resistance in neonatal septicemia.
    Vinodkumar CS; Neelagund YF
    Indian J Pathol Microbiol; 2006 Oct; 49(4):616-9. PubMed ID: 17183878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?].
    Kola A; Gastmeier P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):573-6. PubMed ID: 12975735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
    Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Yang Q; Wang H; Chen M; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Hu Y; Ye H; Badal RE; Xu Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):507-12. PubMed ID: 21036547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
    Chayakulkeeree M; Junsriwong P; Keerasuntonpong A; Tribuddharat C; Thamlikitkul V
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.
    Guembe M; Cercenado E; Alcalá L; Marín M; Insa R; Bouza E
    Rev Esp Quimioter; 2008 Sep; 21(3):166-73. PubMed ID: 18792817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.